Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06188455
What this trial is testing

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
The First Affiliated Hospital of Xiamen University 37
Testing effectiveness (Phase 2)Study completedNCT00003148
What this trial is testing

Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 86
Very early researchWithdrawnNCT01615055
What this trial is testing

Fluoxetine Prevention Trial

Who this might be right for
Cognitive Dysfunction
University of California, Los Angeles
Testing effectiveness (Phase 2)Study completedNCT02945852
What this trial is testing

Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

Who this might be right for
Small Cell Lung Cancer
Fan Yun, MD 40
Not applicableLooking for participantsNCT06537752
What this trial is testing

Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

Who this might be right for
Breast Cancer
Boryung Pharmaceutical Co., Ltd 1,052
Early research (Phase 1)Study completedNCT04879849
What this trial is testing

TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck
Takeda 34
Large-scale testing (Phase 3)Looking for participantsNCT07188584
What this trial is testing

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen 166
Testing effectiveness (Phase 2)Study completedNCT00046852
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
InfectionMultiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Large-scale testing (Phase 3)UnknownNCT03423849
What this trial is testing

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

Who this might be right for
Breast CancerChemotherapy EffectDisease-free Survival
Zhiyong Yu 200
Testing effectiveness (Phase 2)WithdrawnNCT05966233
What this trial is testing

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
Fondazione Italiana Linfomi - ETS
Not applicableUnknownNCT03681938
What this trial is testing

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Who this might be right for
Lymphoma, B-Cell
Institut Paoli-Calmettes 183
Not applicableLooking for participantsNCT06827353
What this trial is testing

Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency

Who this might be right for
Ovarian Carcinoma
Centre Hospitalier Universitaire de Nīmes 300
Not applicableStudy completedNCT02032745
What this trial is testing

Genomic Signatures to Predict Treatment Response

Who this might be right for
Breast Neoplasms
Medical University of Graz 277
Not applicableLooking for participantsNCT04616300
What this trial is testing

Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery

Who this might be right for
Breast Cancer
University of Toronto 50
Not applicableActive Not RecruitingNCT06529302
What this trial is testing

The OPBC-07/microNAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 2,000
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Early research (Phase 1)Study completedNCT02389881
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants

Who this might be right for
Healthy Volunteers
Takeda 40
Not applicableStudy completedNCT06973265
What this trial is testing

Effects of Transcutaneous Electrical Nerve Stimulation on Breast Surgery

Who this might be right for
Breast Cancer SurgeryTranscutaneous Electric Nerve Stimulation
Seda Akutay 48
Large-scale testing (Phase 3)Active Not RecruitingNCT02843191
What this trial is testing

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

Who this might be right for
Rectal Cancer
Kyung Hee University Hospital at Gangdong 358
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07382713
What this trial is testing

Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jinhua Zhou 43
Next Page